CD133 promotes gallbladder carcinoma cell migration through activating Akt phosphorylation

Chen Li; Cong Wang; Yang Xing; Jiaojiao Zhen; Zhilong Ai

doi:10.18632/oncotarget.7474

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

CD133 promotes gallbladder carcinoma cell migration through activating Akt phosphorylation

Chen Li, Cong Wang, Yang Xing, Jiaojiao Zhen and Zhilong Ai _

PDF | HTML | How to cite

Oncotarget. 2016; 7:17751-17759. https://doi.org/10.18632/oncotarget.7474

Metrics: PDF 1694 views | HTML 2169 views | ?

Abstract

Chen Li1,*, Cong Wang1,*, Yang Xing2,*, Jiaojiao Zhen1, Zhilong Ai1

1Zhongshan Hospital of Fudan University, Shanghai, People’s Republic of China

2Key Laboratory of Glycoconjuates Research, Ministry of Public Health, Department of Biochemistry and Molecular Biology, Shanghai Medical College of Fudan University, Shanghai, People’s Republic of China

*These authors contributed equally to this work

Correspondence to:

Zhilong Ai, e-mail: [email protected]

Keywords: CD133, gallbladder carcinoma, migration, invasion, Akt pathway

Received: June 18, 2015 Accepted: January 27, 2016 Published: February 18, 2016

ABSTRACT

Gallbladder carcinoma (GBC) is the fifth most common malignancy of gastrointestinal tract. The prognosis of gallbladder carcinoma is extremely terrible partially due to metastasis. However, the mechanisms underlying gallbladder carcinoma metastasis remain largely unknown. CD133 is a widely used cancer stem cell marker including in gallbladder carcinoma. Here, we found that CD133 was highly expressed in gallbladder carcinoma as compared to normal tissues. CD133 was located in the invasive areas in gallbladder carcinoma. Down-regulation expression of CD133 inhibited migration and invasion of gallbladder carcinoma cell without obviously reducing cell proliferation. Mechanism analysis revealed that down-regulation expression of CD133 inhibited Akt phosphorylation and increased PTEN protein level. The inhibitory effect of CD133 down-regulation on gallbladder carcinoma cell migration could be rescued by Akt activation. Consistent with this, addition of Akt inhibitor Wortmannin markedly inhibited the migration ability of CD133-overexpressing cells. Thus, down-regulation of CD133 inhibits migration of gallbladder carcinoma cells through reducing Akt phosphorylation. These findings explore the fundamental biological aspect of CD133 in gallbladder carcinoma progression, providing insights into gallbladder carcinoma cell migration.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 7474

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

CD133 promotes gallbladder carcinoma cell migration through activating Akt phosphorylation

Abstract